BIO-key International is trading 10.68% lower at $2.60, with broad market weakness potentially contributing to after-hours pressure.
- Shares closed at $2.91 on October 14.
- The supplied market context showed steep declines in the S&P 500 and Nasdaq amid renewed inflation and interest-rate concerns.
- No October 14 company-specific announcement explaining the decline was identified. October 13 customer and leadership announcements preceded the move, but available reporting does not establish them as its cause.